Healthequity Inc Stock Price, News & Analysis

HealthEquity (HQY), the largest independent health savings account custodian in the U.S., will release its fiscal year-end sales results on February 22, 2022, after market close. A conference call is scheduled for the same day at 4:30 PM ET to discuss these results. Management will also attend several investor conferences, including the BTIG Virtual Medtech Conference on February 15, 2022, and the SVB Leerink Annual Global Healthcare Conference on February 16, 2022. A replay of the conference call will be available on the company's investor relations website.

HealthEquity, Inc. (NASDAQ: HQY) reported strong growth for its fiscal year ending January 31, 2022. Estimated HSAs are projected at 7.2 million, up from 5.8 million, and estimated assets reached $19.8 billion, a significant rise from $14.3 billion. Additionally, total accounts are expected to hit around 14.4 million, increasing from 12.8 million. HealthEquity anticipates a yield on HSA cash assets of at least 1.55% for fiscal year 2023. The company plans to discuss these results at the J.P. Morgan Healthcare Conference on January 12, 2022.

HealthEquity reported Q3 results with revenue of $180 million, a slight increase from $179.4 million in Q3 FY21. The company incurred a net loss of $5 million compared to $1.8 million income in the same period last year. Non-GAAP net income decreased by 10% to $28.9 million and adjusted EBITDA remained stable at $61.1 million. The number of HSAs grew by 14% to 6.2 million, while total HSA assets reached $16.4 billion, up by 32%.

Management forecasts $750 million to $755 million in revenue for FY22.

HealthEquity (NASDAQ: HQY) announced its third quarter fiscal 2022 financial results will be released on December 6, 2021, after market hours. A conference call for investors is scheduled for the same day at 4:30 PM ET, where management will discuss the financial highlights. HealthEquity, as the largest independent HSA custodian, serves over 13 million accounts, partnering with employers, benefits advisors, and health plan providers. Investors can participate via a dedicated dial-in or webcast link for detailed insights into the company’s performance.

HealthEquity has completed the acquisition of Further, enhancing its market presence in the HSA sector. This strategic move adds approximately 580,000 HSAs and $1.9 billion in HSA assets, increasing HealthEquity's total to 6.7 million HSAs and $18 billion in assets. The acquisition is valued at $455 million, with an additional potential $45 million dependent on the migration of VEBA assets. It is expected to generate over $12 million in revenue for fiscal year 2022, albeit with less than $1 million in adjusted EBITDA due to implementation costs.

HealthEquity (NASDAQ: HQY) has released the 15th edition of The Complete HSA Guidebook, enhancing the understanding of Health Savings Accounts (HSAs) among benefits professionals and individuals. This updated guide reflects the latest information, organized for easy navigation, with projections indicating a rise to 36 million HSAs and over $127 billion in assets by 2023. The initiative comes amid growing interest in health savings amidst rising healthcare concerns, emphasizing the significance of HSAs as a financial tool for accessing necessary care.

HealthEquity (NASDAQ: HQY) has priced an additional $100 million offering of its 4.500% senior notes due 2029 at 100.75% of face value. This follows a previously announced $500 million offering of the same notes at par. The total of these offerings aims to refinance existing term loans and serve general corporate purposes. Closing is anticipated on October 8, 2021, subject to standard conditions. The notes will be offered to qualified institutional buyers and have not been registered under the Securities Act.

HealthEquity (NASDAQ: HQY) has announced an offering of $100 million in 4.500% senior notes due 2029, complementing a prior $500 million offering. The proceeds will be used to refinance existing term loans and for general corporate purposes. The notes are being offered to qualified institutional buyers and will not be registered under the Securities Act. This offering reflects HealthEquity's strategy to strengthen its financial position and manage debt more effectively.

HealthEquity (NASDAQ: HQY) has announced the pricing of a $500 million offering of 4.500% senior notes due 2029. The net proceeds will be utilized to refinance existing term loans and for general corporate purposes. The offering is set to close on October 8, 2021, pending customary conditions. These senior notes are offered exclusively to qualified institutional buyers under Rule 144A and Regulation S, without registration under the Securities Act of 1933.